Divestments

Divestments are an important part of any corporate company's growth strategy and require the same skill of execution — and dedication to the process — as any other transaction. With a strong track record in company divestitures, undertaken for a multitude of international corporates, we can help you realign your portfolio and redeploy capital to the growth of your core business.

With our experienced team, sector insights and buyer access, we can deliver a transaction at the optimal deal terms and structure.

Divestments Deals

Jul 2022
has divested its API site in Rhode Island, USA, to
May 2021
has formed a strategic alliance with
Jan 2021
has divested its Mirabel manufacturing site in Riom, France to
Jan 2021
has divested its Ringaskiddy analytics and testing site to
Nov 2020
has been acquired by
a division of Constellation Software
Oct 2020
a Calculus Capital-backed company
has divested its mainframe RPA and terminal-emulation products to
a Bain Capital-backed company
Oct 2020
has divested its Poznań, Poland manufacturing site to
Sep 2020
has divested its Barcelona manufacturing sites to
Sep 2020
has divested its Segré, France manufacturing facility to
Jun 2020
has been acquired by
A company backed by TA Associates, HGGC, Charlesbank, Harvest Partners SCF

Results. Great people creating great outcomes, together.

Latest Insights

Corporate News
3rd August 2022

We are joining forces with Canaccord Genuity

We are very excited to share that we have agreed to join forces with Canaccord Genuity – a leading full-service investment bank serving growth companies in the middle market.  This is an important milestone in our journey and we wanted to update you on why we’ve taken this decision and what it means for you. […]

Insights
27th July 2022

Transforming healthcare with real-world evidence (RWE)

The healthcare industry experienced a revolutionary shift when it switched from practising medicine as an art to evidence-based medicine, which is based on relatively simple randomised clinical trials to determine which treatment option was safe and effective. Through the years, evidence-based medicine became the gold standard for clinical development. However, this method has become less […]

Reports
19th July 2022

The Technology Services Perspective – Q2 2022

H1 2022 deal volumes have increased significantly across the board, up 37% over H1 2021. Strategic M&A continues to drive this quarter’s deal activity, namely acquiring footholds in near/offshore hotspots, vendor-specific tech stacks (particularly AWS, Salesforce and SAP) and or next-gen capabilities, such as conversational AI and data analytics. Public tech companies broadly tracked the […]